Diagnostic bone-marrow aspirates of 101 patients with acute leukaemia (54 AML, 37 B-ALL, 8 T-ALL, 2 MPAL) with karyotyping, FISH or multiplex RT-PCR results.
1 evaluation · 83 results. Different protocols are not a single leaderboard.
Applied filters: All linked evaluations
| Tested configuration | Protocol and dataset | Finding | Evidence and details |
|---|---|---|---|
| Configuration: STAR 2.7.7a and Arriba v2.4.0 high-confidence calls with manual IGV review (Kim et al. 2026) | Protocol: Acute leukaemia whole RNA-seq fusion detection against conventional diagnostics (Kim et al. 2026) Dataset: Samsung Medical Center acute leukaemia bone-marrow whole RNA-seq, 101 patients (2022-2023) | 80.8% Percent agreement (overall, 104 fusion detection results in 101 patients) percent · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcerna-fusion-leukaemia-20261011-protocol-conventional-diagnostics Aggregation: Not reported Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia · Results 'Fusion gene detection performance of RNA-seq compared with that of conventional diagnostic methods' paragraph 1: 'The overall concordance rate between RNA-seq and conventional diagnostics was 80.8%.' |
| Configuration: STAR 2.7.7a and Arriba v2.4.0 high-confidence calls with manual IGV review (Kim et al. 2026) | Protocol: Acute leukaemia whole RNA-seq fusion detection against conventional diagnostics (Kim et al. 2026) Dataset: Samsung Medical Center acute leukaemia bone-marrow whole RNA-seq, 101 patients (2022-2023) | 21.4% False positive rate (overall, 56 fusion-negative results by conventional diagnostics; RNA-seq-only fusions counted as errors, though the authors describe several as well-known recurrent fusions and confirmed one by RT-PCR and Sanger sequencing) percent · lower Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcerna-fusion-leukaemia-20261011-protocol-conventional-diagnostics Aggregation: Not reported Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia · Results 'Fusion gene detection performance of RNA-seq compared with that of conventional diagnostic methods' paragraph 1: 'among 56 fusion-negative results based on conventional diagnostics, RNA-seq helped identify 12 fusion genes (21.4%, reflecting 1 – specificity)' |
| Configuration: STAR 2.7.7a and Arriba v2.4.0 high-confidence calls with manual IGV review (Kim et al. 2026) | Protocol: Acute leukaemia whole RNA-seq fusion detection against conventional diagnostics (Kim et al. 2026) Dataset: Samsung Medical Center acute leukaemia bone-marrow whole RNA-seq, 101 patients (2022-2023) | 83.3% Recall (overall, 48 fusions detected by conventional diagnostics) percent · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcerna-fusion-leukaemia-20261011-protocol-conventional-diagnostics Aggregation: Not reported Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia · Results 'Fusion gene detection performance of RNA-seq compared with that of conventional diagnostic methods' paragraph 1: 'Of the 48 fusion genes detected using conventional diagnostics, RNA-seq helped identify 40 and missed eight (83.3% sensitivity)' |
| Configuration: STAR 2.7.7a and Arriba v2.4.0 high-confidence calls with manual IGV review (Kim et al. 2026) | Protocol: Acute leukaemia whole RNA-seq fusion detection against conventional diagnostics (Kim et al. 2026) Dataset: Samsung Medical Center acute leukaemia bone-marrow whole RNA-seq, 101 patients (2022-2023) | 86.4% Recall (AML patients, fusions detected by conventional diagnostics) percent · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcerna-fusion-leukaemia-20261011-protocol-conventional-diagnostics Aggregation: Not reported Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia · Discussion paragraph 2: 'with a fusion detection sensitivity of 83.3%, comparable across AML (86.4%) and B-ALL (87.0%)' |
| Configuration: STAR 2.7.7a and Arriba v2.4.0 high-confidence calls with manual IGV review (Kim et al. 2026) | Protocol: Acute leukaemia whole RNA-seq fusion detection against conventional diagnostics (Kim et al. 2026) Dataset: Samsung Medical Center acute leukaemia bone-marrow whole RNA-seq, 101 patients (2022-2023) | 87% Recall (B-ALL patients, fusions detected by conventional diagnostics) percent · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcerna-fusion-leukaemia-20261011-protocol-conventional-diagnostics Aggregation: Not reported Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia · Discussion paragraph 2: 'with a fusion detection sensitivity of 83.3%, comparable across AML (86.4%) and B-ALL (87.0%)' |
| Configuration: STAR 2.7.7a and Arriba v2.4.0 high-confidence calls with manual IGV review (Kim et al. 2026) | Protocol: Acute leukaemia whole RNA-seq fusion detection against conventional diagnostics (Kim et al. 2026) Dataset: Samsung Medical Center acute leukaemia bone-marrow whole RNA-seq, 101 patients (2022-2023) | 81% Percent agreement (BCR::ABL1 (conventional-positive; AML, B-ALL)) percent · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcerna-fusion-leukaemia-20261011-protocol-conventional-diagnostics Aggregation: Not reported Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia · Table 2, section 'Fusion genes detected using conventional diagnostics', row 'BCR::ABL1', column 'Concordance, %' |
| Configuration: STAR 2.7.7a and Arriba v2.4.0 high-confidence calls with manual IGV review (Kim et al. 2026) | Protocol: Acute leukaemia whole RNA-seq fusion detection against conventional diagnostics (Kim et al. 2026) Dataset: Samsung Medical Center acute leukaemia bone-marrow whole RNA-seq, 101 patients (2022-2023) | 16 Count (BCR::ABL1 (conventional-positive; AML, B-ALL)) count · unknown Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcerna-fusion-leukaemia-20261011-protocol-conventional-diagnostics Aggregation: Not reported Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia · Table 2, section 'Fusion genes detected using conventional diagnostics', row 'BCR::ABL1', column 'Number of fusions detected using conventional diagnostics' |
| Configuration: STAR 2.7.7a and Arriba v2.4.0 high-confidence calls with manual IGV review (Kim et al. 2026) | Protocol: Acute leukaemia whole RNA-seq fusion detection against conventional diagnostics (Kim et al. 2026) Dataset: Samsung Medical Center acute leukaemia bone-marrow whole RNA-seq, 101 patients (2022-2023) | 13 True positives (BCR::ABL1 (conventional-positive; AML, B-ALL)) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcerna-fusion-leukaemia-20261011-protocol-conventional-diagnostics Aggregation: Not reported Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia · Table 2, section 'Fusion genes detected using conventional diagnostics', row 'BCR::ABL1', column 'Number of fusions detected using RNA-seq' |
| Configuration: STAR 2.7.7a and Arriba v2.4.0 high-confidence calls with manual IGV review (Kim et al. 2026) | Protocol: Acute leukaemia whole RNA-seq fusion detection against conventional diagnostics (Kim et al. 2026) Dataset: Samsung Medical Center acute leukaemia bone-marrow whole RNA-seq, 101 patients (2022-2023) | 100% Percent agreement (CBFB::MYH11 (conventional-positive; AML)) percent · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcerna-fusion-leukaemia-20261011-protocol-conventional-diagnostics Aggregation: Not reported Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia · Table 2, section 'Fusion genes detected using conventional diagnostics', row 'CBFB::MYH11', column 'Concordance, %' |
| Configuration: STAR 2.7.7a and Arriba v2.4.0 high-confidence calls with manual IGV review (Kim et al. 2026) | Protocol: Acute leukaemia whole RNA-seq fusion detection against conventional diagnostics (Kim et al. 2026) Dataset: Samsung Medical Center acute leukaemia bone-marrow whole RNA-seq, 101 patients (2022-2023) | 6 Count (CBFB::MYH11 (conventional-positive; AML)) count · unknown Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcerna-fusion-leukaemia-20261011-protocol-conventional-diagnostics Aggregation: Not reported Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia · Table 2, section 'Fusion genes detected using conventional diagnostics', row 'CBFB::MYH11', column 'Number of fusions detected using conventional diagnostics' |
| Configuration: STAR 2.7.7a and Arriba v2.4.0 high-confidence calls with manual IGV review (Kim et al. 2026) | Protocol: Acute leukaemia whole RNA-seq fusion detection against conventional diagnostics (Kim et al. 2026) Dataset: Samsung Medical Center acute leukaemia bone-marrow whole RNA-seq, 101 patients (2022-2023) | 6 True positives (CBFB::MYH11 (conventional-positive; AML)) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcerna-fusion-leukaemia-20261011-protocol-conventional-diagnostics Aggregation: Not reported Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia · Table 2, section 'Fusion genes detected using conventional diagnostics', row 'CBFB::MYH11', column 'Number of fusions detected using RNA-seq' |
| Configuration: STAR 2.7.7a and Arriba v2.4.0 high-confidence calls with manual IGV review (Kim et al. 2026) | Protocol: Acute leukaemia whole RNA-seq fusion detection against conventional diagnostics (Kim et al. 2026) Dataset: Samsung Medical Center acute leukaemia bone-marrow whole RNA-seq, 101 patients (2022-2023) | 100% Percent agreement (DEK::NUP214 (conventional-positive; AML)) percent · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcerna-fusion-leukaemia-20261011-protocol-conventional-diagnostics Aggregation: Not reported Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia · Table 2, section 'Fusion genes detected using conventional diagnostics', row 'DEK::NUP214', column 'Concordance, %' |
| Configuration: STAR 2.7.7a and Arriba v2.4.0 high-confidence calls with manual IGV review (Kim et al. 2026) | Protocol: Acute leukaemia whole RNA-seq fusion detection against conventional diagnostics (Kim et al. 2026) Dataset: Samsung Medical Center acute leukaemia bone-marrow whole RNA-seq, 101 patients (2022-2023) | 1 Count (DEK::NUP214 (conventional-positive; AML)) count · unknown Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcerna-fusion-leukaemia-20261011-protocol-conventional-diagnostics Aggregation: Not reported Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia · Table 2, section 'Fusion genes detected using conventional diagnostics', row 'DEK::NUP214', column 'Number of fusions detected using conventional diagnostics' |
| Configuration: STAR 2.7.7a and Arriba v2.4.0 high-confidence calls with manual IGV review (Kim et al. 2026) | Protocol: Acute leukaemia whole RNA-seq fusion detection against conventional diagnostics (Kim et al. 2026) Dataset: Samsung Medical Center acute leukaemia bone-marrow whole RNA-seq, 101 patients (2022-2023) | 1 True positives (DEK::NUP214 (conventional-positive; AML)) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcerna-fusion-leukaemia-20261011-protocol-conventional-diagnostics Aggregation: Not reported Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia · Table 2, section 'Fusion genes detected using conventional diagnostics', row 'DEK::NUP214', column 'Number of fusions detected using RNA-seq' |
| Configuration: STAR 2.7.7a and Arriba v2.4.0 high-confidence calls with manual IGV review (Kim et al. 2026) | Protocol: Acute leukaemia whole RNA-seq fusion detection against conventional diagnostics (Kim et al. 2026) Dataset: Samsung Medical Center acute leukaemia bone-marrow whole RNA-seq, 101 patients (2022-2023) | 0% Percent agreement (ETV6::NCOA2 (RNA-seq only; MPAL)) percent · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcerna-fusion-leukaemia-20261011-protocol-conventional-diagnostics Aggregation: Not reported Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia · Table 2, section 'Fusion genes detected using RNA-seq only', row 'ETV6::NCOA2', column 'Concordance, %' |
| Configuration: STAR 2.7.7a and Arriba v2.4.0 high-confidence calls with manual IGV review (Kim et al. 2026) | Protocol: Acute leukaemia whole RNA-seq fusion detection against conventional diagnostics (Kim et al. 2026) Dataset: Samsung Medical Center acute leukaemia bone-marrow whole RNA-seq, 101 patients (2022-2023) | 0 Count (ETV6::NCOA2 (RNA-seq only; MPAL)) count · unknown Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcerna-fusion-leukaemia-20261011-protocol-conventional-diagnostics Aggregation: Not reported Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia · Table 2, section 'Fusion genes detected using RNA-seq only', row 'ETV6::NCOA2', column 'Number of fusions detected using conventional diagnostics' |
| Configuration: STAR 2.7.7a and Arriba v2.4.0 high-confidence calls with manual IGV review (Kim et al. 2026) | Protocol: Acute leukaemia whole RNA-seq fusion detection against conventional diagnostics (Kim et al. 2026) Dataset: Samsung Medical Center acute leukaemia bone-marrow whole RNA-seq, 101 patients (2022-2023) | 1 Count (ETV6::NCOA2 (RNA-seq only; MPAL)) count · unknown Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcerna-fusion-leukaemia-20261011-protocol-conventional-diagnostics Aggregation: Not reported Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia · Table 2, section 'Fusion genes detected using RNA-seq only', row 'ETV6::NCOA2', column 'Number of fusions detected using RNA-seq' |
| Configuration: STAR 2.7.7a and Arriba v2.4.0 high-confidence calls with manual IGV review (Kim et al. 2026) | Protocol: Acute leukaemia whole RNA-seq fusion detection against conventional diagnostics (Kim et al. 2026) Dataset: Samsung Medical Center acute leukaemia bone-marrow whole RNA-seq, 101 patients (2022-2023) | 67% Percent agreement (ETV6::RUNX1 (conventional-positive; B-ALL)) percent · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcerna-fusion-leukaemia-20261011-protocol-conventional-diagnostics Aggregation: Not reported Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia · Table 2, section 'Fusion genes detected using conventional diagnostics', row 'ETV6::RUNX1', column 'Concordance, %' |
| Configuration: STAR 2.7.7a and Arriba v2.4.0 high-confidence calls with manual IGV review (Kim et al. 2026) | Protocol: Acute leukaemia whole RNA-seq fusion detection against conventional diagnostics (Kim et al. 2026) Dataset: Samsung Medical Center acute leukaemia bone-marrow whole RNA-seq, 101 patients (2022-2023) | 3 Count (ETV6::RUNX1 (conventional-positive; B-ALL)) count · unknown Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcerna-fusion-leukaemia-20261011-protocol-conventional-diagnostics Aggregation: Not reported Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia · Table 2, section 'Fusion genes detected using conventional diagnostics', row 'ETV6::RUNX1', column 'Number of fusions detected using conventional diagnostics' |
| Configuration: STAR 2.7.7a and Arriba v2.4.0 high-confidence calls with manual IGV review (Kim et al. 2026) | Protocol: Acute leukaemia whole RNA-seq fusion detection against conventional diagnostics (Kim et al. 2026) Dataset: Samsung Medical Center acute leukaemia bone-marrow whole RNA-seq, 101 patients (2022-2023) | 2 True positives (ETV6::RUNX1 (conventional-positive; B-ALL)) count · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcerna-fusion-leukaemia-20261011-protocol-conventional-diagnostics Aggregation: Not reported Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia · Table 2, section 'Fusion genes detected using conventional diagnostics', row 'ETV6::RUNX1', column 'Number of fusions detected using RNA-seq' |
| Configuration: STAR 2.7.7a and Arriba v2.4.0 high-confidence calls with manual IGV review (Kim et al. 2026) | Protocol: Acute leukaemia whole RNA-seq fusion detection against conventional diagnostics (Kim et al. 2026) Dataset: Samsung Medical Center acute leukaemia bone-marrow whole RNA-seq, 101 patients (2022-2023) | 0% Percent agreement (FUS::ZNF362 (RNA-seq only; B-ALL)) percent · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcerna-fusion-leukaemia-20261011-protocol-conventional-diagnostics Aggregation: Not reported Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia · Table 2, section 'Fusion genes detected using RNA-seq only', row 'FUS::ZNF362', column 'Concordance, %' |
| Configuration: STAR 2.7.7a and Arriba v2.4.0 high-confidence calls with manual IGV review (Kim et al. 2026) | Protocol: Acute leukaemia whole RNA-seq fusion detection against conventional diagnostics (Kim et al. 2026) Dataset: Samsung Medical Center acute leukaemia bone-marrow whole RNA-seq, 101 patients (2022-2023) | 0 Count (FUS::ZNF362 (RNA-seq only; B-ALL)) count · unknown Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcerna-fusion-leukaemia-20261011-protocol-conventional-diagnostics Aggregation: Not reported Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia · Table 2, section 'Fusion genes detected using RNA-seq only', row 'FUS::ZNF362', column 'Number of fusions detected using conventional diagnostics' |
| Configuration: STAR 2.7.7a and Arriba v2.4.0 high-confidence calls with manual IGV review (Kim et al. 2026) | Protocol: Acute leukaemia whole RNA-seq fusion detection against conventional diagnostics (Kim et al. 2026) Dataset: Samsung Medical Center acute leukaemia bone-marrow whole RNA-seq, 101 patients (2022-2023) | 1 Count (FUS::ZNF362 (RNA-seq only; B-ALL)) count · unknown Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcerna-fusion-leukaemia-20261011-protocol-conventional-diagnostics Aggregation: Not reported Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia · Table 2, section 'Fusion genes detected using RNA-seq only', row 'FUS::ZNF362', column 'Number of fusions detected using RNA-seq' |
| Configuration: STAR 2.7.7a and Arriba v2.4.0 high-confidence calls with manual IGV review (Kim et al. 2026) | Protocol: Acute leukaemia whole RNA-seq fusion detection against conventional diagnostics (Kim et al. 2026) Dataset: Samsung Medical Center acute leukaemia bone-marrow whole RNA-seq, 101 patients (2022-2023) | 0% Percent agreement (HNRNPH1::ERG (RNA-seq only; AML)) percent · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcerna-fusion-leukaemia-20261011-protocol-conventional-diagnostics Aggregation: Not reported Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia · Table 2, section 'Fusion genes detected using RNA-seq only', row 'HNRNPH1::ERG', column 'Concordance, %' |
| Configuration: STAR 2.7.7a and Arriba v2.4.0 high-confidence calls with manual IGV review (Kim et al. 2026) | Protocol: Acute leukaemia whole RNA-seq fusion detection against conventional diagnostics (Kim et al. 2026) Dataset: Samsung Medical Center acute leukaemia bone-marrow whole RNA-seq, 101 patients (2022-2023) | 0 Count (HNRNPH1::ERG (RNA-seq only; AML)) count · unknown Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourcerna-fusion-leukaemia-20261011-protocol-conventional-diagnostics Aggregation: Not reported Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia · Table 2, section 'Fusion genes detected using RNA-seq only', row 'HNRNPH1::ERG', column 'Number of fusions detected using conventional diagnostics' |
Source checking is not independent reproduction. Release 2026-10-22-1b7cf027e4f6.
0 of 4 readiness checks met. These checks assess whether the evidence supports a reproducible investigation; a source-checked score alone does not meet them.
Release 2026-10-22-1b7cf027e4f6 · Evidence verified: Not verified
Exact outcomes, predictions, identifiers and evaluator are connected.
Missing or unresolved evidence
Verified: Not verified
Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.
Missing or unresolved evidence
Verified: Not verified
A pinned recipe describes the inputs, environment and resource requirements.
Missing or unresolved evidence
Verified: Not verified
Separate data and exposure records support an independent test.
Missing or unresolved evidence
Verified: Not verified
Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.
No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.
A dataset supplies biological observations. The evaluation protocol defines how those observations are split, used and scored.
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
6 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| Assay Illumina Stranded mRNA Prep, NextSeq 550Dx or NovaSeq 6000, 2 x 150 bp; median 90 million reads (range 14 to 1,021 million) Context-only references | Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia Methods 'Patients and samples', 'RNA-seq and fusion gene detection'; Table 1 Version: Annals of Laboratory Medicine 46(3), epub 2025-10-16; PMC13071280 full-text XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Population 101 patients, September 2022 to September 2023; 104 fusion detection results Context-only references | Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia Methods 'Patients and samples', 'RNA-seq and fusion gene detection'; Table 1 Version: Annals of Laboratory Medicine 46(3), epub 2025-10-16; PMC13071280 full-text XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Source location Methods 'Patients and samples', 'RNA-seq and fusion gene detection'; Table 1 Context-only references | Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia Methods 'Patients and samples', 'RNA-seq and fusion gene detection'; Table 1 Version: Annals of Laboratory Medicine 46(3), epub 2025-10-16; PMC13071280 full-text XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Split Retrospective clinical cohort Context-only references | Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia Methods 'Patients and samples', 'RNA-seq and fusion gene detection'; Table 1 Version: Annals of Laboratory Medicine 46(3), epub 2025-10-16; PMC13071280 full-text XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Description Diagnostic bone-marrow aspirates of 101 patients with acute leukaemia (54 AML, 37 B-ALL, 8 T-ALL, 2 MPAL) with karyotyping, FISH or multiplex RT-PCR results. Context-only references | Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia Methods 'Patients and samples', 'RNA-seq and fusion gene detection'; Table 1 Version: Annals of Laboratory Medicine 46(3), epub 2025-10-16; PMC13071280 full-text XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Name Samsung Medical Center acute leukaemia bone-marrow whole RNA-seq, 101 patients (2022-2023) Context-only references | Detection of Fusion Genes Using RNA Sequencing in Acute Leukemia Methods 'Patients and samples', 'RNA-seq and fusion gene detection'; Table 1 Version: Annals of Laboratory Medicine 46(3), epub 2025-10-16; PMC13071280 full-text XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Release 2026-10-22-1b7cf027e4f6 · Record review: source checked
Stable ID: rna-fusion-leukaemia-20261011-data-smc-acute-leukaemia